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Aim: Cellular senescence, leading to cell death through prevention of regular cell renewal, is associated with
the upregulation of the tumor suppressor gene p16INK4a. While this mechanism has been described as leading
to progressive nephron loss, p16INK4a upregulation in renal cell carcinoma has been linked to a disease-
speciﬁc improved patient survival rate. While in both conditions endothelin-1 is also upregulated, the signal-
ing pathway connecting ET-1 to p16INK4a has not been characterized until this study.
Main methods: Cell culture, qRT-PCR, Western Blot, immunoprecipitation (IP), proximity ligation assay (PLA),
and non-radioactive electrophoretic mobility shift assay (EMSA).
Key ﬁndings: In malignant renal proximal tumor cells (Caki-1), an activation of p16INK4a and p21waf1/cip1 was
observed. An increased expression of E-26 transformation-speciﬁc (ETS) transcription factors was detectable.
Using speciﬁc antibodies, a complex formation between ETS1 and extracellular signal-regulated kinase-2
(ERK2) was shown. A further complex partner was Mxi2. EMSA with supershift analysis for ETS1 and Mxi2
indicated the involvement of both factors in the protein–DNA interaction. After speciﬁcally blocking the
endothelin receptors, ETS1 expression was signiﬁcantly downregulated. However, the endothelin B receptor
dependent downregulation was stronger than that of the A receptor. In contrast, primary proximal tubule
cells showed a nuclear decrease after ET-1 stimulation. This indicates that other ETS members may be in-
volved in the observed p16INK4a upregulation (as described in the literature).
Signiﬁcance: ETS1, ERK2 andMxi2 are important complex partners initiating increased p16INK4a and p21waf1/cip1
activation in renal tumor cells.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Cellular senescence is an aging mechanism that prevents cell re-
newal leading to apoptosis, and increased expression of the tumor
suppressor gene p16INK4a (Verzola et al., 2008). The target p16INK4a
functions as an inhibitor of cyclin dependent kinases 4 and 6, which
are responsible for the initiation of phosphorylation of the retinoblas-
toma protein, pRb. This deﬁnes the function of p16INK4a as a tumor
suppressor gene, interfering with common cell cycle arrest and apo-
ptosis. Its overexpression or loss of function is commonly related to
oncogenesis (Hui et al., 2000; Krimpenfort et al., 2001) such as in
renal cell carcinoma (Maruschke et al., 2011). In RCC, its expression
indicates a better disease-speciﬁc survival rate (Ikuerowo et al.,
2007). Upon deregulation of gene expression, cell cycle arrest andniversity Hospital of Cologne,
221 478 6061; fax: +49 221
ies).
-NC-ND license.apoptosis can no longer be properly regulated. In 2001, Ohtani et al.
demonstrated that E-26 transformation-speciﬁc (ETS) transcription
factor family members are able to activate p16INK4a promoter via an
ETS-binding site in ﬁbroblasts (Ohtani et al., 2001).
Besides the p16-Rb pathway, senescence is also controlled by
the p53-p21waf1/cip1 pathway (Jung et al., 2010). The p21waf1/cip1
gene, localized on chromosome 6p21.2, produces a smaller 132
amino acid protein due to alternative promoters and splicing. It
has been found to induce premature senescence in both normal
and tumor cells (Lin et al., 1998) in a p53-dependent manner. It
is also elevated in prematurely senescent ﬁbroblasts from human
or mice with premature aging syndromes. In the kidney, Ortmann
et al. (2004) observed that an improvement of structural injury in
glomeruli and podocytes was accompanied by a reduction of the
expression of p21waf1/cip1. In renal tumor cells (Caki-1) p21waf1/cip1
upregulation has been described as pro-apoptotic mechanism targeted
by different reagents such as monensin (Park et al., 2003), phenyla-
cetate (Franco et al., 2003), and interleukin-4 (Yu et al., 2004).
Gene regulation of p21waf1/cip1 is mediated by the direct binding of
p53 to two highly conserved p53-response elements. Several other
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and E-boxes (reviewed in Jung et al., 2010). In 2003, Zhang et al. de-
scribed ETS-1 transcriptional activation of p21waf1/cip1 as protective
mechanism in vascular smoothmuscle cells fromundergoing apoptosis.
ETS is an evolutionally recent class of transcription factors; among
these are ETS-1, ETS-2, Elk1 and GABPα. In the kidney, different ETS
proteins have been reported as being upregulated and having greater
impact than other family members, such as ETS1 and 2 (Hollenhorst
et al., 2004). All ETS proteins have a highly conserved, helix-turn-
helix core consensus sequence as DNA binding domain with a central
5-GGA(A-T)-3 core motif (Jedlicka and Gutierrez-Hartmann, 2008).
ETS proteins are important in the regulation of: proliferation,migration,
differentiation and apoptosis; but upregulation or increased ampliﬁca-
tion can be as well associated with oncogenesis (Gutierrez-Hartmann
et al., 2007; Puri et al., 2006). An importantmolecular feature regulating
the transcription of genes is the pointed domain (PNT). The PNT of ETS1
contains an extracellular signal-regulated kinase 2 (ERK2) docking site
that enhances the phosphorylation of a mitogen-activated protein ki-
nase (MAPK) site, N-terminal to the PNT domain (Seidel and Graves,
2002).
MAPKs are cytoplasmic serine/threonine kinases, activated by ex-
tracellular stimuli such as: cell proliferation, differentiation, and in-
ﬂammation. Various isoforms and splicing variants have been
identiﬁed for p38α. Among them, Mxi2 is identical to p38α in the
ﬁrst 280 amino acids, harboring a unique 17 amino acid C-terminus
(Zervos et al., 1995). Mxi2 is most abundant in renal tissues (Faccio
et al., 2000), can bind to ERK1/2 and regulates its nuclear transport
(Sanz-Moreno et al., 2003).
Endothelin-1 plays a major role as mediator of cellular signaling in
primary renal proximal tubule cells (Ong et al., 1995) and their malig-
nant counterparts from renal cell carcinoma, Caki-1 cells (von
Brandenstein et al., 2008). This signal transmission is mediated via
the Endothelin A (ETA) receptor, present in both human cell types
(Gerstung et al., 2007; von Brandenstein et al., 2011). In this context,
we demonstrated an ET-receptor dependent, protein–protein interac-
tion between: nuclear factor-kappa B (NF-κB) p65, mitogen-activated
protein kinase (MAPK) p38 and protein kinase C alpha (PKCα) as part
of the transcription complex (von Brandenstein et al., 2008, 2011).
Since ETS and Mxi2 are present in the kidney, and ERK may be upre-
gulated after endothelin-1 stimulation via the ETA receptor (Chen et
al., 2009), these factors seemed likely candidates for a signiﬁcant
role in p16INK4a activation. In this study we investigated whether
endothelin-1 and its two ET-receptors are involved in the signaling
function via ETS, Mxi2 and MAPK transcription to regulate p16INK4a
activation in human renal carcinoma and normal proximal tubule
cells.Materials and methods
All reagents used were commercially available at Sigma-Aldrich,
except when otherwise speciﬁed. All experiments were performed
in triplicates, except when otherwise speciﬁed.Blobﬁnder
For quantiﬁcation of the Eurogentec experiment the free com-
mercial software, Blobﬁnder, was used according to the manufac-
turer's recommendation (http://www.cb.uu.se/~amin/BlobFinder/).
To quantify differences not readily visible by microscopic inspec-
tion, this program can help by analyzing the images based on a
single cell analysis. This analysis simulates cytoplasm and assigns
each signal to a particular cell. In the output, every cell has a
value representing the number of signals in that particular cell
compartment.Cell culture
Caki-1 (renal cell carcinoma cell line) and RPTEC (primary renal
proximal tubule epithelial cell line) cells were cultured as previously
described (Gerstung et al., 2007; von Brandenstein et al., 2008, 2011).
Cell treatments
Cells were treated with endothelin-1 (50 nM) for different time
points. Before treatments the cells were serum starved for 24 h.
Endothelin A and B receptor blocks were done as previously de-
scribed (Gerstung et al., 2007).
Densitometry
For densitometric analysis the ImageJ program was used accord-
ing to the protocols. A measuring area was placed around the individ-
ual signal and its intensity was measured. The same area was then
used to measure the background signal (noise) of the respective
Western blot. The two values were subtracted from each other. The
same procedure was followed for all signals and their respective
Western blot “noise.” To determine the net signal of each band, the
corresponding calculated value of the β-actin loading was regarded
as 100%, and the proportional value of each of the protein signals
was calculated.
The same procedure was followed analyzing the EMSAs including
the supershift. After the signal-to-noise ratio was calculated, the
untreated control Caki-1 cells were regarded as 100% and squared
with the ET-1 treated ones. The two supershift bands were equally
squared with their untreated controls.
Immunoprecipitation
For immunoprecipitation, either ETS1, ERK2 or Mxi2 agarose con-
jugated antibody (Santa Cruz) was used. The assay was performed
according to the Santa Cruz protocol with 1000 μg total cellular pro-
tein. The ﬁnal washing step was done 3× with PBS and the samples
were diluted in 5 μl 2× electrophoresis sample buffer. After a boiling
step of 4 min, the samples were centrifuged and used for Western
blot analysis.
Non-radioactive electrophoretic mobility shift assay (EMSA)
Nuclear extracts were isolated from endothelin treated and
untreated cells according to the manufacturer's protocol (Nuclear ex-
traction kit, Active motif). Protein content was assayed with the Brad-
ford protein assay (Bio-Rad) with BSA as standard. Double stranded
p16INK4a oligonucleotides (Alexa 660 TTC CGC CAG CAC CGG AGG
AAG AAA GA) were commercially synthesized (Invitrogen) and the
forward strand was labeled with Alexa 660. p16INK4a binding reac-
tions were conducted in 200 mM TRIS–HCL pH 7.6, 50 mM MgCl2,
0.1 mM EDTA and 10 mM DTT. To prepare the DNA for annealing,
the oligonucleotides (1.5 nmol each) were incubated at 70 °C for ex-
actly 10 min and a further 30 min at room temperature. For the pro-
tein/DNA binding reaction, 20 μg of protein was added to the
samples and incubated on ice for 30 min. The reaction was analyzed
by electrophoresis in a non-denaturation 6% polyacrylamide gel in
1× TBE buffer. For supershift EMSAs, ETS1 or Mxi2 antibody (Santa
Cruz) was used. As negative control, 200× more concentrated non-
labeled, “cold” p16INK4a oligonucleotide was incubated with 20 μg of
protein and added to the Alexa labeled sample. As a binding and neg-
ative control, a mutated p16INK4a (Alexa 660 CTT CCG CCA GCA CCG
GCT TCC TAA AGA, Invitrogen) oligo was used. All EMSAs were per-
formed in triplicates and visualized with a ﬂuorescence reader (Li-
cor, Licor Biosciences).
Fig. 1. Expression level of ETS transcription factors in Caki-1 cells. Subconﬂuent cells
were stimulated with 50 nM ET-1 for 3, 6, and 24 h. After RNA extraction, 250 ng was
reverse transcribed, and a PCR reaction was performed using primers for ETS transcrip-
tion factors. PCR products were analyzed on a 2% agarose gel. The experiment, starting
from ET-1 treatment of Caki-1 cells, was performed in triplicate.
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AGG TCA GCT GCG TTA GAG GAA GAA GAC T) (Zhang et al., 2003),
the mutated oligonucleotide (Cy5 AGG TCA GCT GCG TTA GAT CCG
AAG ACT), the corresponding reverse strand was unlabelled. The
p21waf1/cip1 oligos were synthesized by euroﬁns mwg operon. The
EMSA was performed as mentioned above; the running time was
120 min.
Nuclear extract and cytoplasmic isolation
Nuclear and cytoplasmic extracts were isolated from treated cells
and controls according to the manufacturer's protocol (nuclear ex-
traction kit, Active motif). Protein content was assayed with the Brad-
ford protein assay (Bio-Rad) with bovine serum albumin as standard.
Proximity ligation assay by Duolink kit
1×104 Caki-1 cells grown on Labtecs were washed with PBS and
incubated according to the manufacturer's protocol (OLink Biosci-
ence). The mixture was incubated in DMEM at room temperature
for 15 min. DMEM was removed; the cells were washed with PBS
and treated with 50 nm ET-1 for 24 h. For ﬁxation, a methanol:ace-
tone (1:1, v/v) mixture was used. After removal of DMEM, slides
were washed in PBS, air dried, and incubated in ice-cold methanol:ac-
etone (1:1, v/v) for 90 s. After the ﬁxation procedure, the Duolink kit
was used according to the manufacturer's instructions. The cells were
incubated with a blocking solution in a pre-heated humidity chamber
at 37 °C for 30 min, followed by primary antibody incubation for 2 h
at room temperature. Incubation with the PLA probes for 1.5 h at
37 °C followed, and the detection protocol; according to the recom-
mended time points; was applied. After completing the ﬁnal step,
slides were mounted in Invitrogen ﬂuorescence mounting medium
with DAPI (Invitrogen) for nuclear staining. The Leica Aristoplan mi-
croscope with Discus software was used for visualization.
RNA isolation
RNA was isolated with the RNeasy kit from Qiagen according to
the manufacturer's protocol. RNA was quantiﬁed using the NanoDrop
technology.
RT-PCR
The cDNAwas obtained from250 ngRNAusing randomprimers and
SuperScript III reverse transcriptase according to the manufacturer's
protocol (Invitrogen). In order to be in the semi-quantitative range,
the amount of cDNA was previously determined by titration and the
number of PCR cycles was standardized. The PCR reactions were per-
formed in a ﬁnal volume of 25 μl. For PCR reaction, 1 μl of the RT-PCR
product was always used and mixed with RedTaq Ready Mix (Sigma)
or Platinum Taq polymerase (Invitrogen) according to the manufac-
turer's protocol. The PCR reactions were performed with 35 cycles con-
sisting of 0.5–1 min at 94 °C, 1 min at 55 °C annealing temperature,
1 min at 72 °C with a ﬁnal extension for 10 min at 72 °C.
Primers: β-actin, forward: TTG GCA ATG AGC GGT TCC GCT G, re-
verse: TAC ACG TGT TTG CGG ATG TCC AC, temperature 55 °C, 35 cy-
cles; ETS1 forward: ACC CAG CCT ATC CAG AAT CC, reverse: TCT GCA
AGG TGT CTG TCT GG; ELF-1 forward: TCA AGT CCA GGG GTA AAA
GG, reverse: TTC ATC CTG CAT GGT ACT GG, temperature 55 °C, 35 cy-
cles; ELK1 forward: CCA CCT TCA CCA TCC AGT CT, reverse: AAC CCG
GCT CCA CAT TAA G, temperature 55 °C, 35 cycles; ESE1-ELF3 for-
ward: GCA ACT ACT TCA GTG CGA TGT AC, reverse: CAG TCC AGA
ACC TGC GTC TT, temperature 55 °C, 35 cycles; ES3-EHF forward:
GGA AGG AGG TGG TGT AAT GAA TC, reverse CCA CTC CCA CAC CTG
GTA CT, temperature 55 °C, 35 cycles; ETS2 forward: CAA GGC TGT
GAT GAG TCA AGC, reverse: GGT GCC AGC TCC AGA AAG C,temperature 55 °C, 35 cycles; GABPα forward: CAC CAT GCT GAA
TCA GAA GC, reverse: TGC TGA ATT CCT TCA TTA CCC, temperature
55 °C, 35 cycles; MEF-ELF4 forward GCA GCA CCA TCT ATC TGT GG,
reverse: ACT GGT ACA CCA GCC TCT GC, temperature 55 °C, 35 cycles;
NERF-ELF2 forward: ACC ACT GCA TCT GTG TCA GC, reverse: TGC ATG
GTG ATT TTG TCTC C, temperature 55 °C, 35 cycles; NET-ELK3 forward
TCC ACT GCT CTC CAG CAT AC, reverse: GGA GAA GCA GCT CTG TGT
CCA, temperature 55 °C, 35 cycles; PU.1 forward: CCA CTG GAG GTG
TCT GAC G, reverse: GTC ATC TTC TTG CGG TTG C, temperature
55 °C, 35 cycles; SAP1-ELK4 forward: GCA GAA GCC TCA GAA CAA
GC, reverse: TTG GAT CCA TGT TCA AAA TCT CTG G, temperature
55 °C, 35 cycles; TEL-ETV6 forward: CCA TCA ACC TCT CTC ATC GG re-
verse: GGC TCT GGA CAT TTT CTC ATA GG, temperature 55 °C, 35 cy-
cles; TEL-ETV7 forward: AGG GCT TAC CAG CAA CTT CG, reverse: GGG
CTC ATA TCG GGT ATC AA, temperature 55 °C, 35 cycles; p16INK4a for-
ward: CTT CCT GGA CAC GCT GGT, reverse: GCA TGG TTA CTG CCT
CTG GT, temperature 50 °C, 35 cycles.
Statistics
All experiments were performed in triplicate.
The GraphPrism 5 program was used for performing statistical
analysis. After the analysis of variance (one way ANOVA) was per-
formed, signiﬁcant differences were calculated using mean±SEM.
Western blot analysis
Western blot analysis was performed as previously described
(Gerstung et al., 2007; von Brandenstein et al., 2011, 2008) For the
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Cruz were used and tested for speciﬁcity with Santa Cruz designed
peptides.
Results
Endothelin-1 dependent ETS transcription family members
ETS transcription factor family members were analyzed in tripli-
cate for their expression patterns in Caki-1 cells. To study the inﬂu-
ence of time on ET-1 stimulation, cells were treated for 3, 6, and
24 h with 50 nM ET-1 (Fig. 1). The PCR products were analyzed by
agarose gel electrophoresis on a 2% agarose gel, run at 120 V. After
24 h ET-1 stimulation a decrease of expression was detectable for all
ETS transcription factors. However, ETS1, ETS2 and GABPα showed
an increased expression after 6 h ET-1 stimulation. All three tran-
scription factors were analyzed byWestern blot. Since ETS1 upregula-
tion was the strongest among these three proteins, it was chosen for
further analysis.
Cytoplasmic versus nuclear expression of ETS1 in ET-1 stimulated Caki-1
cells
20 μg protein isolated from the cytoplasmic and nuclear fraction of
50 nM ET-1 stimulated Caki-1 cells was used for Western blot analy-
sis (Fig. 2) (n=3). β-actin levels showed equal loading of protein. An
increase of nuclear ETS1 was observed after ET-1 stimulation over
time, compared to nuclear controls (p≤0.001). In contrast, after ET-
1 stimulation no signiﬁcant change in ETS1 levels in the cytoplasm
could be observed after 24 h treatment (Fig. 2A and B). Fig. 2C and
D demonstrates the ETS2 expression over time in the cytoplasmic
and nuclear fraction. After ET-1 treatment no migration of ETS2 was
detectable.Fig. 2.Western blot analysis was performed in triplicate for ETS transcription factors in Caki-
ET-1 stimulation with 50 nM for 6, and 24 h was used. β-actin served as a loading control. I
performed Western blots; changes were not signiﬁcant. Cyto: cytoplasmic; NE: nuclear extEndothelin receptor dependent ETS1 expression
After 24 h of serum starvation, Caki-1 cells were either treated
with ET-1 for 24 h or the endothelin A or B receptor was speciﬁcally
blocked 1 h before ET-1 treatment. As shown in Fig. 3A (n=3), statis-
tically signiﬁcant reduction of ETS1 protein levels in the nucleus was
detected after either ETA or ETB receptor block. However, the ETS1 re-
duction was more signiﬁcant after ETBR block (Fig. 3B).
Analysis of participating proteins in complex formation after ET-1
stimulation
As it was already known that ETS1 presents a docking site for
ERK2, immunoprecipitation was done with ETS1 and ERK2 conjugat-
ed agarose beads (in triplicate; Fig. 4). 1000 μg total cellular extract
was immunoprecipitated from Caki-1 cells stimulated with 50 nM
ET-1 for 24 h, followed byWestern blot analysis. The setups identiﬁed
a complex formation between ETS1 and ERK2. The same approach
was used to identify the complex formation between ERK2 and
Mxi2. To ensure that all three proteins are present in the same com-
plex, immunoprecipitation with ETS1 and Mxi2 conjugated agarose
beads was also performed. The results obtained indicated a complex
formation between ETS1, ERK2 and Mxi2.
Cellular location of protein complex in Caki-1 cells
To analyze the location of the complex in the cell, duplicate prox-
imity ligation assays were performed (Fig. 5). A complex formation
between ETS1 and ERK2 as well as ERK2 and Mxi2 was detected. In
both experimental setups all cells were positive for DAPI. The cells
showed multiple ﬂuorescent dots in the nucleus, indicating positive
signals for the tested complex partners. Pairwise comparison of con-
trol cell populations against ET-1 stimulated cell populations revealed1 cells. In A and C, 20 μg protein from prepared nuclear or cytoplasmic cell extracts after
n B, densitometric analysis of performed Western blots. In D, densitometric analysis of
ract.
Fig. 3. In A, Western blot analysis of ETS1 protein levels after speciﬁc block of the endothelin receptors (n=3) followed by ET-1 treatment. β-actin served as a loading control. In B,
densitometric analysis of Western blot: results of the ANOVA with Bonferroni method indicated by stars.
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signals per cell from 1.9 to 2.7 for ETS1 and ERK2 and an increase in
signals per cell from 2.0 to 2.2 for the complex between ERK2 and
Mxi2 after endothelin-1 treatment were detected. The quantiﬁcation
of ﬂuorescent signals was done by using the Blobﬁnder program. The
results conﬁrm a complex formation between ETS1, ERK2 and Mxi2,
already observed in immunoprecipitation. A location of the complexFig. 4. Immunoprecipitation analysis of transcription complex. 1000 μg of total cell ex-
tracts from Caki-1 cells, stimulated with 50 nM ET-1 for 24 h was immunoprecipitated
using agarose beads conjugated with antibodies against ERK2, ETS1, and Mxi2. After
boiling and pelleting of the agarose beads, the supernatant was loaded onto an SDS-
PAGE and blotted, and the associated proteins detected with speciﬁc antibodies. The
experiments were performed in triplicate.partners in the nucleus is seen, indicating a migration of the complex
into the nucleus.Cytoplasmic—nuclear transmigration
Immunoprecitation, in duplicate, of total cellular protein, isolated
from 50 nM ET-1 stimulated cells for 24 h, was performed with
ETS1 coated agarose beads. Following Western blot analysis, using
antibodies against α and β-subunits of importins, we did not identify
any importins involved in nuclear translocation (data not shown).Endothelin receptor dependent p16INK4a expression and electrophoretic
mobility shift assay analysis of binding partners in the transcription complex
and their binding speciﬁcity
After treatment of the Caki-1 cells, p16INK4a PCR was performed
and the PCR product was analyzed on a 2% agarose gel. Signiﬁcantly
decreased p16INK4a expression levels were detected after ETBR block.
By EMSA analysis, the binding of the ETS1-ERK2-Mxi2 transcrip-
tion factor complex on the target gene p16INK4a was tested to investi-
gate the activation of p16INK4a (Fig. 6B). Nuclear cell extracts from
Caki-1 cells stimulated for 24 h with 50 nM ET-1 were incubated
with oligonucleotides, representing the p16INK4a promoter sequence
for ETS. A supershift analysis for ETS1 and Mxi2 was performed. The
results show a shift for both, ETS1 and Mxi2, before and after ET-1
stimulation of the cells. The EMSAs were performed four times, al-
ways showing the same speciﬁcity. Samples incubated with oligonu-
cleotides mutated in their consensus sequence, revealed a decrease in
their ﬂuorescent signal. A signiﬁcant decrease of the p16INK4a signal
was found in the case of Mxi2 supershift analysis. This indicates that
Fig. 5. Duolink in situ proximity ligation assay. 1×104 Caki-1 cells were grown on Labtecs, stimulated for 24 h with 50 nM ET-1 (n=2). Protein complex formation was detected by
speciﬁc antibodies coupled to oligonucleotides, which were detected after a ligation step with ﬂuorescently labeled complementary oligonucleotides, leading to a nuclear, dot-like,
ﬂuorescent signal. Nuclear counterstain was performed using DAPI mounting medium (top row). In column A, the complex formation between ETS-1 with ERK-2 is shown with an
increase in dots per cell from 1.9 to 2.7 after ET-1 stimulation. In column B, the complex formation between ERK-2 with Mxi-2 can be seen, with an increase in dots per cell after ET-
1 stimulation from 2.0 to 2.2 The last row is an enlargement of row 3 (both columns), highlighting visible nuclear dot-like ﬂuorescent signals (indicated by arrows).
567M. von Brandenstein et al. / Life Sciences 91 (2012) 562–571the ETS1 binding site is essential for Mxi2 binding, since it is pre-
vented by mutation analysis (Fig. 6B).
Comparison of ET-1 mediated ETS-1 induction in malignant Caki-1 versus
primary RPTEC
As all experiments were performed in Caki-1 cells, the regulation
of protein expression of ETS1 was tested in the non-malignant origin
of Caki-1 cells, namely primary human RPTEC. Western blot analysis
was carried out to show the protein expression of ETS1 in cytoplasmic
and nuclear cell extracts (n=3), after 50 nM ET-1 stimulation in both
cell lines (Fig. 7). In Caki-1 cells, the amount of ETS1 was higher in the
nucleus than in the cytoplasm with a signiﬁcant increase after ET-1
stimulation. In contrast, in RPTEC the reverse could be seen: cytoplas-
mic content of ETS1 highly exceeded that of the nucleus. Further-
more, the amount of ETS1 dropped after ET-1 stimulation, while
simultaneously being raised in the cytoplasm to the same amount
(Fig. 7B).
Discussion
This study describes a cytoplasmic complex formation of three
proteins: ETS1, ERK2, and Mxi2 after endothelin-1 stimulation, and
their nuclear transmigration, leading to the upregulation of thetumor suppressor gene p16INKa (see Fig. 8) in malignant renal proxi-
mal tubule cells.
In renal clear cell carcinoma, the most prevalent of all encountered
malignant, renal parenchymal tumors, the expression of the tumor sup-
pressor gene p16INK4a has been described as downregulated. This was
associated with a malignant phenotype as in other tumors. In contrast,
the detection of p16INK4a expression in such tumors could be related
to a tumor-speciﬁc improvement of patient survival (Ikuerowo et al.,
2007). Thus, the analysis of transcription factors leading to its expres-
sion is helpful in understanding p16INK4a regulation and provides a
basis for potential therapeutic approach. Since p16INK4a contains a pro-
moter with an ETS factor speciﬁc binding site, we primarily analyzed
the induction of ETS family members in the context of renal tumor
cells after ET-1. The selection of speciﬁc members tested was based on
previous work fromHollenhorst et al. (2004), showing that in renal tis-
sue only a limited number of ETS family members were to be expected.
Surprisingly, from those present only ETS1, ETS2 and GABPα showed
signiﬁcant upregulation after ET-1 stimulation (Fig. 1). Only ETS1
showed a highly statistically signiﬁcant temporal regulation (Fig. 2A),
with an increased presence in the nucleus at 24 h after ET-1. No increase
of protein level was detectable in the nucleus for either ETS2 (Fig. 2B) or
for GABPα (data not shown) Therefore, it is possible that the upregu-
lated mRNA levels, detectable by PCR, undergo posttranscriptional
modiﬁcations (Fig. 9).
Fig. 6. In panel A, expression level of p16INK4a transcription factors in Caki-1 cells. Subconﬂuent cells were treated with a speciﬁc ETAR or ETBR blocker or/ and stimulated with
50 nM ET-1 for 24 h (after block). After RNA extraction, 250 ng was reverse transcribed, and a PCR reaction was performed using primers for ETS transcription factors. PCR products
were analyzed on a 2% agarose gel (n=2). In B, non-radioactive EMSA representing p16INK4a promoter sequence with supershift analysis for ETS1 and Mxi2. 20 μg nuclear extracts
from Caki-1 cells were incubated with forward Alexa660 labeled oligonucleotides and reverse unlabeled oligonucleotides. For supershift analysis, ETS1 or Mxi2 antibody was pre-
incubated for 1.5 h with the nuclear extract. Samples were loaded onto a 6% non-denaturing polyacrylamide gel and run at 100 V for 180 min. The EMSAs were performed four
times, always showing the same speciﬁcity. For densitometric analysis shown in B, the signal intensity of the appropriated sample was calculated and the untreated Caki-1 cells
were regarded as 100%.
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ERK2 (Seidel and Graves, 2002) is reported in literature, and ERK2 is
known to form a complex with Mxi2 (Casar et al., 2007). Thus, it was
tempting to investigate whether (i) these factors play a role in the
setting of renal tumor signaling as well, and (ii) whether there
might be a complex formation between all three factors as we de-
scribed for MAPKp38, NF-κB p65 and PKCα after ET-1 stimulation in
a variety of malignant tumor cells, including Caki-1 cells (von
Brandenstein et al., 2008, 2011). In immunoprecipitation experi-
ments with either ETS1, ERK2 or Mxi2 conjugated to agarose beads,
interaction between the three proteins could be demonstrated
(Fig. 4). Thus, a transcription complex consisting of all three proteins
was detectable. Since, due to experimental restrictions, total cell ex-
tracts were used for this experiment, an independent method was
employed to visualize the presence of this complex. In Caki-1 cells,
the use of paired speciﬁc antibodies against either ETS1 and ERK2
(Fig. 5A) or ERK-2 and Mxi-2 (Fig. 5B) combined with oligonucleotide
coupled secondary antibodies resulted in a nuclear ﬂuorescent signal
in the Duolink in situ proximity ligation assay, as predicted for com-
plexes in which proteins involved are in close proximity (Fig. 5).Nuclear transmigration may occur as a complex or by each protein
individually. In analogy to our study showing the involvement of
importins 4 and 5 as chaperone for the nuclear transmigration of
the NF-κBp65/MAPK p38/PKCα complex (von Brandenstein et al.,
2011), the potential involvement of the α-subunits and the β-subunit
of importins was investigated by immunoprecipitation and subse-
quent Western blotting using speciﬁc antibodies (data not shown).
However, no direct binding could be observed. Thus, we currently
have to speculate whether or not the phosphorylated proteins may
enter the nucleus by active transport (Formstecher et al., 2001;
Whitehurst et al., 2004) individually, such as it was suggested for
ERK1/2 after phosphorylation (Lenormand et al., 1993). Alternatively,
it has been speculated that Mxi2 itself may serve as a chaperone pro-
tein (Casar et al., 2007). Finally, importin 8, which is a protein binding
to the nuclear pore complex, and shares a sequence motif related to
the Ran-binding site of importin β (Weinmann et al., 2009), could
also serve as a potential chaperone.
p16INK4a has a known binding site for ETS proteins in its promoter,
raising the question of whether ETS1 after nuclear transmigration
would bind as an individual protein or whether the entire newly
Fig. 7. Non-radioactive EMSA representing p21waf1/cip1 promoter sequence with supershift analysis for ETS1 and Mxi2. 20 μg nuclear extracts from Caki-1 cells were incubated with
forward Alexa660 labeled oligonucleotides and reverse unlabeled oligonucleotides. For supershift analysis, ETS1 or Mxi2 antibody was pre-incubated for 1.5 h with the nuclear ex-
tract. Samples were loaded onto a 6% non-denaturing polyacrylamide gel and run at 100 V for 120 min. The EMSAs were performed four times, always showing the same speciﬁcity.
For densitometric analysis shown in B, the signal intensity of the appropriated sample was calculated and the untreated Caki-1 cells were regarded as 100%.
569M. von Brandenstein et al. / Life Sciences 91 (2012) 562–571identiﬁed transcription factor complex was part of the p16INK4a tran-
scription machinery. An EMSA with subsequent supershift analysis
for ETS1 and Mxi2 reveals that both proteins bind as a complex to
the p16INK4a promoter in Caki-1 cells (Fig. 6B). The speciﬁcity of this
binding can be demonstrated by mutating the ETS binding of the
p16INK4a promoter with a signiﬁcant loss of activity. In addition, the
importance of the ﬂanking sequence of the ETS-binding site isFig. 8. Nuclear and cytoplasmic ETS1 protein expression in Caki-1 versus primary
human proximal tubule epithelial cells (RPTEC). Western blots were performed in trip-
licate. In panel A, Western blot analysis of cytoplasmic and nuclear extracts from Caki-1
versus RPTEC cells stimulated with 50 nM ET-1 for 24 h were analyzed with an ETS1
antibody. β-actin served as a loading control. In panel B, densitometric analysis of per-
formed Western blots.shown by a dramatic loss of signal intensity. A signiﬁcant decrease
of the p16INK4a signal was found in case of Mxi2 supershift analysis,
indicating that the ETS1 binding site is essential for Mxi2 binding as
shown by mutation analysis (Fig. 6B).
We also investigated the question which of the two endothelin re-
ceptors is important for p16INK4a production. After speciﬁc block of
the two receptors, followed by ET-1 treatment, the mRNA expression
was analyzed. As it can be seen in Fig. 6A, both blocking experiments
lead to a reduction of the p16INK4a expression level, however, the
ETBR block was more signiﬁcant. This result correlates with our pre-
viously ﬁndings where both receptor blocks lead to a reduction of
the protein level of ETS1. In this case, the ETBR block was also more
signiﬁcant and resulted in a decrease of ETS1 protein levels in theFig. 9. Schematic presentation of the signaling cascade connecting ET-1 stimulation to
p16INK4a activation in Caki-1 cells according to the results of this study. After ET-1 stim-
ulation ETS1 forms a complex with ERK2 and Mxi2, which is translocated into the nu-
cleus, where the complex binds via ETS1 to the ETS-binding site in the p16INK4a
promoter, initiating p16INK4a gene expression.
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the p16INK4a promoter region shown by EMSA (Fig. 6B) and leading
therefore to an activation of p16INK4a expression, a decrease of ETS1
after ETBR block leads to a reduction of p16INK4a levels. This result dif-
fers from the one reported by Terada et al. (1998) who found that the
p16INK4a activation is endothelin A receptor dependent. Furthermore,
ET-1 stimulated [3H] thymidine incorporation, CDK4 kinase activity,
and prevention of cells in S phases were signiﬁcantly inhibited by
the overexpression of p16INK4a and slightly inhibited by the overex-
pression of p21waf1/cip1. This result seems puzzling, since others
have reported the involvement of the ETB receptor as mediator of
ET-1 stimulation in mesangial proliferative glomerulonpehritis in
the rat (Yoshimura et al., 1995). Here, the model system used (cell
culture versus animal model) as well as additional unknown factors
co-activated by ET1 stimulation may play a yet important but undis-
covered role. This difference between our observation and Terada et
al. (1998) may be explained in part by the use of different cell types
(mesangial vs tubular epithelial cells) as well as the use of different
species (rat versus human), since the signaling loop seems to be spe-
cies as well as cell type speciﬁc (Gerstung et al., 2007).
p21waf1/cip1 has a functional binding site for ETS proteins in its
promoter (Zhang et al., 2003), raising the question of whether ETS1
after nuclear transmigration would bind as an individual protein or
whether the entire newly identiﬁed transcription factor complex
was also part of the p21waf1/cip1 transcription machinery. An EMSA
with subsequent supershift analysis for ETS1, ERK2 and Mxi2 reveals
that both proteins bind as a complex to the p21waf1/cip1 promoter in
Caki-1 cells (Fig. 7). The speciﬁcity of this binding can be demonstrat-
ed by mutating the ETS binding of the p21waf1/cip1 promoter with a
signiﬁcant loss of activity.
Caki-1 cells are the malignant counterpart of proximal renal tu-
bule cells. In those tubule cells, protein loss through the glomerular
basement membrane in a variety of immunologic and non-
immunologic diseases has been identiﬁed as an important patho-
physiologic mechanism for p16INK4a upregulation (Sis et al., 2007)
In the context of proteinuric stimulation, ET-1 seems to be a major
stimulus for proximal tubule activation (Abbate et al., 2006; Zoja et
al., 2003). The current notion is that tubular injury may exhaust ﬁnite
replicative capacity. This could be detrimental to renal function, since
it leads to progressive nephron loss with replacement ﬁbrosis, ulti-
mately causing chronic renal insufﬁciency and necessitating dialysis
(Meyer, 2003). Because ETS1 binding via its speciﬁc binding site to
the p16INK4a promoter can be considered essential for p16INK4a tran-
scription, we investigated the cytoplasmic and nuclear temporal ex-
pression proﬁle of ETS1 in human primary renal proximal tubule
cells (RPTEC). Pathophysiological activation was mimicked by adding
ET-1 to the culture medium for 24 h. The result in Fig. 8 shows that
the majority of ETS1 expression is located in the cytoplasm and only
about one-fourth of detectable protein is found in the nucleus in
RPTECs. Unexpectedly, this result changes after ET-1 stimulation op-
posite to that observed in malignant Caki-1 cells, i.e., the amount of
ETS1 decreases in the nucleus, and the decreased amount seems to
be added to the amount of detectable protein in the cytoplasm, pre-
sumably by nuclear export. This result is in contrast to the observed
increase in p16INK4a immunostaining in proximal tubules in proteinu-
ric conditions (Sis et al., 2007), indicating that under proteinuric con-
ditions in normal proximal tubule cells other members of the ETS
family may be responsible for p16INK4a binding and thus necessitating
further studies.Conclusion
In conclusion, we demonstrate that in renal carcinoma a transcrip-
tion complex, consisting of: ETS1, ERK2 and Mxi2 is responsible for in-
creased p16INK4a protein expression, leading to an improved diseasesurvival, according to the literature. Furthermore, it was also possible
to show that the p16INK4a expression is ETBR>ETAR dependent.
In this context, ET-1 is a helpful adjunct by further promoting
p16INK4a expression. Since ETS1 is decreased in the nuclei of normal
proximal kidney cells after ET-1 stimulation potentially observed in
proteinuria, other members of the ETS transcription family may be re-
sponsible for the observed p16INK4a overexpression under these
circumstances.
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